Brinase
Enzyme
N
Y (what is this?) (verify) Brinase (or brinolase) is a fibrinolytic enzyme, and a thrombolytic drug.[1]
It is derived from Aspergillus oryzae.[2]
See also
- Aspergillus oryzae
References
- ^ Frisch EP (July 1972). "Clinical experience with brinase". Journal of Clinical Pathology. 25 (7): 654–5. doi:10.1136/jcp.25.7.654. PMC 477472. PMID 5070274.
- ^ Roschlau WH (July 1972). "Thrombolytic properties and side effects of brinase (fibrinolytic enzyme from Aspergillus oryzae) in the dog". Journal of Clinical Pathology. 25 (7): 635–6. doi:10.1136/jcp.25.7.635. PMC 477457. PMID 5070267.
External links
- Brinolase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- v
- t
- e
Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)
| Glycoprotein IIb/IIIa inhibitors |
|
|---|---|
| ADP receptor/P2Y12 inhibitors |
|
| Prostaglandin analogue (PGI2) | |
| COX inhibitors | |
| Thromboxane inhibitors | |
| Phosphodiesterase inhibitors | |
| Other |
| Vitamin K antagonists (inhibit II, VII, IX, X) | |||||
|---|---|---|---|---|---|
| Factor Xa inhibitors (with some II inhibition) |
| ||||
| Direct thrombin (IIa) inhibitors |
| ||||
| Other |
fibrinolytics
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
